Science Explorer Back to mapMap

Mario Ojeda‐Uribe

Mario Ojeda‐Uribe publishes mostly in Hematology, Genetics and Immunology, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Myeloproliferative Neoplasms: Diagnosis and Treatment.

ORCID 0000-0001-6881-6055 OpenAlex
World rank
#2,257,266
of 7,710,434 ranked researchers
Rank in France
#97,180
of 324,115
Works
107
Citations
2k
Citations per work
18.3
h-index
22
i10-index 35Top 21% in Hematology

What does Mario Ojeda‐Uribe research?

Mario Ojeda‐Uribe's work is mostly in Medicine (54%), Immunology and Microbiology (8%), Biochemistry, Genetics and Molecular Biology (6%).

Life Sciences14%Health Sciences54%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5753.5%
  1. Everything else3532.3%
    1. Immunology and Microbiology98.4%
    2. Biochemistry, Genetics and Molecular Biology65.8%
  1. 1Hematology30% of their works
  2. 2Genetics12% of their works
  3. 3Immunology8% of their works
  4. 4Oncology8% of their works
  5. 5Molecular Biology6% of their works
  6. 6Public Health, Environmental and Occupational Health4% of their works

Research topics

Which keywords describe Mario Ojeda‐Uribe's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Minimal Residual Disease, BCR-ABL, Imatinib and JAK2 Mutation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors623 topics
  2. AML361 topic
  3. Acute Myeloid Leukemia361 topic
  4. Rituximab272 topics
  5. Minimal Residual Disease222 topics
  6. BCR-ABL191 topic
  7. Imatinib191 topic
  8. JAK2 Mutation161 topic
  9. Myelofibrosis161 topic
  10. Chronic Lymphocytic Leukemia141 topic
  11. Genomic Aberrations141 topic
  12. Classification131 topic
  13. Lymphoma131 topic
  14. Acute Lymphoblastic Leukemia121 topic
  15. Childhood Cancer121 topic
  16. Complement111 topic
  17. Immune111 topic
  18. Diagnosis Criteria101 topic
  19. International Myeloma Working Group101 topic

Where does Mario Ojeda‐Uribe work?

Mario Ojeda‐Uribe's main affiliation in the publication record is Centre Hospitalier de Mulhouse, France.

How many publications and citations does Mario Ojeda‐Uribe have?

OpenAlex counts 107 works and 1,953 citations for Mario Ojeda‐Uribe, an h-index of 22, ranking #2,257,266 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mario Ojeda‐Uribe. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.